Phosphoramidites

3'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-5'-CE-Phosphoramidite

Description: 3'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-5'-CE-Phosphoramidite is a specialized nucleotide used in oligonucleotide synthesis. It contains a 3'-dimethoxytrityl (DMTr) protecting group on the 3' hydroxyl, a 2'-O-methoxyethyl (MOE) modification at the 2' position of the ribose sugar, a methyl (Me) modification at the 5' position of the cytosine base, and a benzoyl (Bz) protecting group on the cytosine amino group. Additionally, it features a 5'-cyanoethyl (CE) phosphoramidite functionality for controlled addition during synthesis. This compound facilitates stable and precise synthesis of customized oligonucleotides, useful for various molecular biology research applications.

CAT: BRP-00592

CAS: 3025999-57-6

Molecular Formula: C50H60N5O10P

Molecular Weight: 922.03

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: LGQSXYUXQBROPP-GICDFOIUSA-N

CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)COP(N(C(C)C)C(C)C)OCCC#N)OC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OCCOC

IUPAC Name: N-[1-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-5-[[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxymethyl]-3-(2-methoxyethoxy)oxolan-2-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C50H60N5O10P/c1-34(2)55(35(3)4)66(62-29-15-28-51)63-33-43-44(65-50(38-18-13-10-14-19-38,39-20-24-41(59-7)25-21-39)40-22-26-42(60-8)27-23-40)45(61-31-30-58-6)48(64-43)54-32-36(5)46(53-49(54)57)52-47(56)37-16-11-9-12-17-37/h9-14,16-27,32,34-35,43-45,48H,15,29-31,33H2,1-8H3,(H,52,53,56,57)/t43-,44-,45-,48-,66?/m1/s1

Synonyms: Rev 2'-O-MOE-5MeC(Bz)-5'-amidite; ((2R,3R,4R,5R)-5-(4-benzamido-5-methyl-2-oxopyrimidin-1(2H)-yl)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-4-(2-methoxyethoxy)tetrahydrofuran-2-yl)methyl (2-cyanoethyl) diisopropylphosphoramidite

3'-O-DMTr-2'-O-MOE-rA(Bz)-5'-CE-Phosphoramidite

Description: 3'-O-DMTr-2'-O-MOE-rA(Bz)-5'-CE-Phosphoramidite is a specialized nucleotide derivative used in oligonucleotide synthesis. It features a 3'-dimethoxytrityl (DMTr) protecting group on the 3' hydroxyl, a 2'-O-methoxyethyl (MOE) modification at the 2' position of the ribose sugar, and a benzoyl (Bz) protecting group on the adenine (A) base. Additionally, it contains a 5'-cyanoethyl (CE) phosphoramidite functionality, enabling controlled addition during synthesis. This compound facilitates stable and precise synthesis of customized oligonucleotides, making it valuable for molecular biology research applications.

CAT: BRP-00593

CAS: 3025999-68-9

Molecular Formula: C50H58N7O9P

Molecular Weight: 932.03

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: XNXRGROTYZFYBK-HDMAWCRFSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OCC1C(C(C(O1)N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)OCCOC)OC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC

IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-5-[[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxymethyl]-3-(2-methoxyethoxy)oxolan-2-yl]purin-6-yl]benzamide

InChI: InChI=1S/C50H58N7O9P/c1-34(2)57(35(3)4)67(63-28-14-27-51)64-31-42-44(66-50(37-17-12-9-13-18-37,38-19-23-40(60-6)24-20-38)39-21-25-41(61-7)26-22-39)45(62-30-29-59-5)49(65-42)56-33-54-43-46(52-32-53-47(43)56)55-48(58)36-15-10-8-11-16-36/h8-13,15-26,32-35,42,44-45,49H,14,28-31H2,1-7H3,(H,52,53,55,58)/t42-,44-,45-,49-,67?/m1/s1

Synonyms: Rev 2'-O-MOE-A(Bz)-5'-amidite; ((2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)-4-(2-methoxyethoxy)tetrahydrofuran-2-yl)methyl (2-cyanoethyl) diisopropylphosphoramidite

3'-O-DMTr-2'-O-MOE-rG(iBu)-5'-CE-Phosphoramidite

Description: 3'-O-DMTr-2'-O-MOE-rG(iBu)-5'-CE-Phosphoramidite is a specialized nucleotide derivative used in oligonucleotide synthesis. It features a 3'-dimethoxytrityl (DMTr) protecting group on the 3' hydroxyl, a 2'-O-methoxyethyl (MOE) modification at the 2' position of the ribose sugar, and a benzoyl (Bz) protecting group on the adenine (A) base. Additionally, it contains a 5'-cyanoethyl (CE) phosphoramidite functionality, enabling controlled addition during synthesis. This compound facilitates stable and precise synthesis of customized oligonucleotides, making it valuable for molecular biology research applications.

CAT: BRP-00594

CAS: 725223-44-9

Molecular Formula: C47H60N7O10P

Molecular Weight: 914.00

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: YLDSIMQFLQLTEA-SBCRAQIVSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C(C(C(O3)COP(N(C(C)C)C(C)C)OCCC#N)OC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)OCCOC

IUPAC Name: N-[9-[(2R,3R,4R,5R)-4-[bis(4-methoxyphenyl)-phenylmethoxy]-5-[[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxymethyl]-3-(2-methoxyethoxy)oxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C47H60N7O10P/c1-30(2)43(55)51-46-50-42-39(44(56)52-46)49-29-53(42)45-41(60-27-26-57-7)40(38(63-45)28-62-65(61-25-13-24-48)54(31(3)4)32(5)6)64-47(33-14-11-10-12-15-33,34-16-20-36(58-8)21-17-34)35-18-22-37(59-9)23-19-35/h10-12,14-23,29-32,38,40-41,45H,13,25-28H2,1-9H3,(H2,50,51,52,55,56)/t38-,40-,41-,45-,65?/m1/s1

Synonyms: Rev 2'-O-MOE-G(iBu)-5'-amidite; Guanosine, 3'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)-, 5'-[2-cyanoethyl bis(1-methylethyl)phosphoramidite]

U PMO Monomer

Description: U PMO Monomer is a monomer used in the synthesis of peptide-conjugated morpholino oligomers (PMO). PMOs are synthetic nucleic acid analogs designed for antisense therapy and gene expression modulation. The ''U'' designation indicates that the monomer is based on uracil, a nucleobase commonly used in nucleic acid analogs. These monomers are incorporated into PMOs to specifically target and bind complementary RNA sequences, thereby interfering with gene expression or splicing mechanisms.

CAT: BRP-00595

CAS: 2388517-98-2

Molecular Formula: C30H32ClN4O5P

Molecular Weight: 595.03

Purity: ≥98%

Appearance: White to faint yellow powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 1.320±0.06 g/cm3

InChIKey: GCLNBTZDWZLIOP-JOLGRYLWSA-N

CanonicalSMILES: CN(C)P(=O)(OCC1CN(CC(O1)N2C=CC(=O)NC2=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)C5=CC=CC=C5)Cl

IUPAC Name: 1-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C30H32ClN4O5P/c1-33(2)41(31,38)39-22-26-20-34(21-28(40-26)35-19-18-27(36)32-29(35)37)30(23-12-6-3-7-13-23,24-14-8-4-9-15-24)25-16-10-5-11-17-25/h3-19,26,28H,20-22H2,1-2H3,(H,32,36,37)/t26-,28+,41?/m0/s1

Synonyms: ((2S,6R)-6-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methyl dimethylphosphoramidochloridate; [(2S,6R)-6-(3,4-Dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-4-(triphenylmethyl)-2-morpholinyl]methyl N,N-dimethylphosphoramidochloridate; Morpholino U

O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer

Description: O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer is a modified guanosine (G) monomer used in the synthesis of peptide-conjugated morpholino oligomers (PMO). It features a pivaloyloxymethyl (p-tolyl pivalate) group at the O6 position and a phenylacetyl (PhAc) group at the N2 position, providing protection to the guanine base during oligomer synthesis. PMOs are synthetic nucleic acid analogs designed for antisense therapy and gene expression modulation. These monomers are incorporated into PMOs to specifically target and bind complementary RNA sequences, thereby interfering with gene expression or splicing mechanisms.

CAT: BRP-00596

CAS: 1155309-89-9

Molecular Formula: C51H53ClN7O7P

Molecular Weight: 942.44

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 1.29±0.1 g/cm3

InChIKey: TXKNJPOHRYJGGF-UHFFFAOYSA-N

CanonicalSMILES: CC(C)(C)C(=O)OC1=CC=C(C=C1)COC2=NC(=NC3=C2N=CN3C4CN(CC(O4)COP(=O)(N(C)C)Cl)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)NC(=O)CC8=CC=CC=C8

IUPAC Name: [4-[[9-[6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-2-[(2-phenylacetyl)amino]purin-6-yl]oxymethyl]phenyl] 2,2-dimethylpropanoate

InChI: InChI=1S/C51H53ClN7O7P/c1-50(2,3)48(61)66-41-28-26-37(27-29-41)33-63-47-45-46(55-49(56-47)54-43(60)30-36-18-10-6-11-19-36)59(35-53-45)44-32-58(31-42(65-44)34-64-67(52,62)57(4)5)51(38-20-12-7-13-21-38,39-22-14-8-15-23-39)40-24-16-9-17-25-40/h6-29,35,42,44H,30-34H2,1-5H3,(H,54,55,56,60)

Synonyms: Propanoic acid, 2,2-dimethyl-, 4-[[[9-[6-[[[chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl ester; Activated DPG Subunit; 4-[[[9-[6-[[[Chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl 2,2-dimethylpropanoate; PMO G(PhAc) Phosphoramidite

4-(((9-((2R,6S)-6-(((Chloro(dimethylamino)phosphoryl)oxy)methyl)-4-tritylmorpholin-2-yl)-2-(2-phenylacetamido)-9H-purin-6-yl)oxy)methyl)phenyl pivalate

Description: 4-(((9-((2R,6S)-6-(((Chloro(dimethylamino)phosphoryl)oxy)methyl)-4-tritylmorpholin-2-yl)-2-(2-phenylacetamido)-9H-purin-6-yl)oxy)methyl)phenyl pivalate is a complex molecular structure used in oligonucleotide synthesis. This structure likely serves as a protecting group or linker in the synthesis of nucleic acid analogs, enabling the controlled assembly of oligonucleotide sequences. The compound's design incorporates functionalities for efficient coupling reactions and protection of sensitive chemical groups during solid-phase synthesis.

CAT: BRP-00597

CAS: 1044241-66-8

Molecular Formula: C51H53ClN7O7P

Molecular Weight: 942.44

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

Density: 1.29±0.1 g/cm3

InChIKey: TXKNJPOHRYJGGF-OHCUOHFYSA-N

CanonicalSMILES: CC(C)(C)C(=O)OC1=CC=C(C=C1)COC2=NC(=NC3=C2N=CN3C4CN(CC(O4)COP(=O)(N(C)C)Cl)C(C5=CC=CC=C5)(C6=CC=CC=C6)C7=CC=CC=C7)NC(=O)CC8=CC=CC=C8

IUPAC Name: [4-[[9-[(2R,6S)-6-[[chloro(dimethylamino)phosphoryl]oxymethyl]-4-tritylmorpholin-2-yl]-2-[(2-phenylacetyl)amino]purin-6-yl]oxymethyl]phenyl] 2,2-dimethylpropanoate

Synonyms: Propanoic acid, 2,2-dimethyl-, 4-[[[9-[(2R,6S)-6-[[[chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl ester; 4-[[[9-[(2R,6S)-6-[[[Chloro(dimethylamino)phosphinyl]oxy]methyl]-4-(triphenylmethyl)-2-morpholinyl]-2-[(2-phenylacetyl)amino]-9H-purin-6-yl]oxy]methyl]phenyl 2,2-dimethylpropanoate; O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer

DMTr-2'-O-4'-C-ethylene-rU-3'-CE-Phosphoramidite

Description: DMTr-2'-O-4'-C-ethylene-rU-3'-CE-Phosphoramidite, utilized in oligonucleotide synthesis, exhibits increased stability and binding properties owing to the incorporation of an ethylene linker at the 2'-O and 4'-C positions of uridine (rU). The presence of a cyanoethyl (CE) group at the 3'-end facilitates efficient coupling reactions during solid-phase synthesis. It is particularly useful in the generation of modified RNA molecules for various biological applications, such as RNA interference (RNAi) and antisense therapy.

CAT: BRP-00598

CAS: 287737-49-9

Molecular Formula: C41H49N4O9P

Molecular Weight: 772.84

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: WGXJDXATSZPKMD-JOFAAVELSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C2C(OC1(CCO2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)N6C=CC(=O)NC6=O

IUPAC Name: 3-[[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-(2,4-dioxopyrimidin-1-yl)-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy-[di(propan-2-yl)amino]phosphanyl]oxypropanenitrile

InChI: InChI=1S/C41H49N4O9P/c1-28(2)45(29(3)4)55(52-25-10-23-42)54-37-36-38(44-24-21-35(46)43-39(44)47)53-40(37,22-26-50-36)27-51-41(30-11-8-7-9-12-30,31-13-17-33(48-5)18-14-31)32-15-19-34(49-6)20-16-32/h7-9,11-21,24,28-29,36-38H,10,22,25-27H2,1-6H3,(H,43,46,47)/t36-,37+,38-,40-,55?/m1/s1

Synonyms: 2,4(1H,3H)-Pyrimidinedione, 1-[2,6-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-; 1-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-2,4(1H,3H)-pyrimidinedione; ENA-U Phosphoramidite

DMTr-2'-O-4'-C-ethylene-rC(Bz)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-4'-C-ethylene-rC(Bz)-3'-CE-Phosphoramidite, employed in oligonucleotide synthesis, features an ethylene linker at the 2'-O and 4'-C positions of cytidine (rC), along with benzoyl (Bz) protection on the cytosine amino group. The cyanoethyl (CE) group at the 3'-end facilitates efficient coupling reactions during solid-phase synthesis. This modified nucleotide finds application in the creation of RNA sequences with enhanced stability and binding affinity, suitable for gene silencing studies and RNA-based therapeutics.

CAT: BRP-00599

CAS: 287737-36-4

Molecular Formula: C48H54N5O9P

Molecular Weight: 875.96

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: IZEZSKXQKDNBEX-HAUVADMLSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C2C(OC1(CCO2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)N6C=CC(=NC6=O)NC(=O)C7=CC=CC=C7

IUPAC Name: N-[1-[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-8-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2,6-dioxabicyclo[3.2.1]octan-7-yl]-2-oxopyrimidin-4-yl]benzamide

InChI: InChI=1S/C48H54N5O9P/c1-33(2)53(34(3)4)63(60-30-13-28-49)62-43-42-45(52-29-26-41(51-46(52)55)50-44(54)35-14-9-7-10-15-35)61-47(43,27-31-58-42)32-59-48(36-16-11-8-12-17-36,37-18-22-39(56-5)23-19-37)38-20-24-40(57-6)25-21-38/h7-12,14-26,29,33-34,42-43,45H,13,27,30-32H2,1-6H3,(H,50,51,54,55)/t42-,43+,45-,47-,63?/m1/s1

Synonyms: N-[1-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide; (1R,5R,7R,8S)-7-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-2,6-dioxabicyclo[3.2.1]octan-8-yl (2-cyanoethyl) diisopropylphosphoramidite; ENA-C(Bz) Phosphoramidite

DMTr-2'-O-4'-C-ethylene-rA(Bz)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-4'-C-ethylene-rA(Bz)-3'-CE-Phosphoramidite, used in oligonucleotide synthesis, contains an ethylene linker at the 2'-O and 4'-C positions of adenosine (rA), with benzoyl (Bz) protection on the adenine amino group. The cyanoethyl (CE) group at the 3'-end facilitates efficient coupling reactions during solid-phase synthesis. It is employed in the construction of RNA sequences with augmented stability and binding affinity, suitable for various research applications including RNA-targeted therapy and gene expression modulation.

CAT: BRP-00600

CAS: 287737-45-5

Molecular Formula: C49H54N7O8P

Molecular Weight: 899.99

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: IUGJZRODLODQAN-QLRWGQFGSA-N

CanonicalSMILES: CC(C)N(C(C)C)P(OCCC#N)OC1C2C(OC1(CCO2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)N6C=NC7=C(N=CN=C76)NC(=O)C8=CC=CC=C8

IUPAC Name: N-[9-[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-8-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2,6-dioxabicyclo[3.2.1]octan-7-yl]purin-6-yl]benzamide

InChI: InChI=1S/C49H54N7O8P/c1-33(2)56(34(3)4)65(62-28-13-27-50)64-43-42-47(55-32-53-41-44(51-31-52-45(41)55)54-46(57)35-14-9-7-10-15-35)63-48(43,26-29-60-42)30-61-49(36-16-11-8-12-17-36,37-18-22-39(58-5)23-19-37)38-20-24-40(59-6)25-21-38/h7-12,14-25,31-34,42-43,47H,13,26,28-30H2,1-6H3,(H,51,52,54,57)/t42-,43+,47-,48-,65?/m1/s1

Synonyms: Benzamide, N-[9-[2,6-anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-9H-purin-6-yl]-; ENA-A(bz) Phosphoramidite; N-[9-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-9H-purin-6-yl]benzamide

DMTr-2'-O-4'-C-ethylene-rG(iBu)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-4'-C-ethylene-rG(iBu)-3'-CE-Phosphoramidite, utilized in oligonucleotide synthesis, features an ethylene linker at the 2'-O and 4'-C positions of guanosine (rG), with isobutyryl (iBu) protection on the guanine amino group. The cyanoethyl (CE) group at the 3'-end facilitates efficient coupling reactions during solid-phase synthesis. This modified nucleotide is valuable for generating RNA sequences with enhanced stability and binding affinity, suitable for applications such as RNA interference (RNAi) and RNA therapeutics.

CAT: BRP-00601

CAS: 287737-58-0

Molecular Formula: C46H56N7O9P

Molecular Weight: 881.97

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: VXCXNHPZXAIEDO-DNUXVXCXSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2C3C4C(C(O3)(CCO4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)OP(N(C(C)C)C(C)C)OCCC#N

IUPAC Name: N-[9-[(1R,5R,7R,8S)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-8-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2,6-dioxabicyclo[3.2.1]octan-7-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C46H56N7O9P/c1-29(2)41(54)50-44-49-40-37(42(55)51-44)48-28-52(40)43-38-39(62-63(60-25-12-24-47)53(30(3)4)31(5)6)45(61-43,23-26-58-38)27-59-46(32-13-10-9-11-14-32,33-15-19-35(56-7)20-16-33)34-17-21-36(57-8)22-18-34/h9-11,13-22,28-31,38-39,43H,12,23,25-27H2,1-8H3,(H2,49,50,51,54,55)/t38-,39+,43-,45-,63?/m1/s1

Synonyms: ENA-G(iBu) Phosphoramidite; N-[9-[2,6-Anhydro-4-C-[[bis(4-methoxyphenyl)phenylmethoxy]methyl]-3-O-[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]-5-deoxy-α-L-lyxo-hexofuranosyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-2-methylpropanamide; (1R,5R,7R,8S)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-7-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-2,6-dioxabicyclo[3.2.1]octan-8-yl (2-cyanoethyl) diisopropylphosphoramidite

DMTr-2'-O-C22-rA(Bz)-3'-CE-Phosphoramidite

Description: DMTr-2'-O-C22-rA(Bz)-3'-CE-Phosphoramidite, utilized in oligonucleotide synthesis, contains a DMTr protecting group at the 5'-position and a cyanoethyl (CE) group at the 3'-end. The nucleoside unit is adenosine (rA), modified with a C22 linker at the 2'-O position and benzoyl (Bz) protection on the adenine amino group. It is employed in the synthesis of RNA sequences with enhanced stability and binding affinity, suitable for various research applications including RNA-based therapy and gene expression modulation.

CAT: BRP-00603

CAS: 2923115-67-5

Molecular Formula: C69H96N7O8P

Molecular Weight: 1182.54

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: BCBFIURHCBIJCZ-GOQGTMNZSA-N

CanonicalSMILES: N#CCCOP(OC1C(OC(N2C=NC=3C(=NC=NC32)NC(=O)C=4C=CC=CC4)C1OCCCCCCCCCCCCCCCCCCCCCC)COC(C=5C=CC=CC5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)N(C(C)C)C(C)C

IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(docosyloxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite

InChI: InChI=1S/C69H96N7O8P/c1-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-26-33-48-80-64-63(84-85(82-49-34-47-70)76(53(2)3)54(4)5)61(83-68(64)75-52-73-62-65(71-51-72-66(62)75)74-67(77)55-35-29-27-30-36-55)50-81-69(56-37-31-28-32-38-56,57-39-43-59(78-6)44-40-57)58-41-45-60(79-7)46-42-58/h27-32,35-46,51-54,61,63-64,68H,8-26,33-34,48-50H2,1-7H3,(H,71,72,74,77)/t61-,63-,64-,68-,85?/m1/s1

5'-O-DMT-2'-O-MOE-rG(iBu)-3'-((2-cyanoethoxy)(diisopropylamino)phosphoramidite)-ethyl-diisopropylphosphoramidite

Description: 5'-O-DMT-2'-O-MOE-rG(iBu)-3'-((2-cyanoethoxy)(diisopropylamino)phosphoramidite)-ethyl-diisopropylphosphoramidite, utilized in oligonucleotide synthesis, features a 5'-O-DMT protecting group and contains a diisopropylamino group for coupling with the next nucleotide. The nucleoside unit is guanosine (rG), modified with a 2'-O-methoxyethyl (MOE) group and isobutyryl (iBu) protection on the guanine amino group. It also contains a phosphoramidite group for solid-phase synthesis. It finds application in the construction of RNA sequences with enhanced stability and target specificity, suitable for various research applications including RNA-based therapeutics and gene editing.

CAT: BRP-00604

Molecular Formula: C55H78N8O12P2

Molecular Weight: 1105.22

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: LVJZCNKMRFOXEH-XOHXKFSOSA-N

IUPAC Name: (2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl (2-(((2-cyanoethoxy)(diisopropylamino)phosphaneyl)oxy)ethyl) diisopropylphosphoramidite

InChI: InChI=1S/C55H78N8O12P2/c1-36(2)51(64)59-54-58-50-47(52(65)60-54)57-35-61(50)53-49(69-31-30-66-11)48(75-77(63(39(7)8)40(9)10)73-33-32-72-76(71-29-17-28-56)62(37(3)4)38(5)6)46(74-53)34-70-55(41-18-15-14-16-19-41,42-20-24-44(67-12)25-21-42)43-22-26-45(68-13)27-23-43/h14-16,18-27,35-40,46,48-49,53H,17,29-34H2,1-13H3,(H2,58,59,60,64,65)/t46-,48-,49-,53-,76?,77?/m1/s1

5'-O-DMT-2'-O-MOE-5-Me-rC(Bz)-3'-((2-cyanoethoxy)(diisopropylamino)phosphoramidite)-ethyl-diisopropylphosphoramidite

Description: 5'-O-DMT-2'-O-MOE-5-Me-rC(Bz)-3'-((2-cyanoethoxy)(diisopropylamino)phosphoramidite)-ethyl-diisopropylphosphoramidite, employed in oligonucleotide synthesis, features a 5'-O-DMT protecting group and contains a diisopropylamino group for coupling with the next nucleotide. The nucleoside unit is 5-methylcytidine (5-Me-rC), modified with a 2'-O-methoxyethyl (MOE) group and benzoyl (Bz) protection on the cytosine amino group. Additionally, it contains a phosphoramidite group for solid-phase synthesis. The presence of a cyanoethoxy group at the 3'-end facilitates efficient coupling reactions during synthesis. This compound is valuable in generating modified RNA sequences with enhanced stability and target specificity, suitable for various research applications including RNA-based therapeutics and gene editing.

CAT: BRP-00605

Molecular Formula: C58H78N6O12P2

Molecular Weight: 1113.24

Purity: ≥98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: GEBJJSSJUVBPKC-UBMNREJOSA-N

IUPAC Name: (2R,3R,4R,5R)-5-(4-benzamido-5-methyl-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl (2-(((2-cyanoethoxy)(diisopropylamino)phosphaneyl)oxy)ethyl) diisopropylphosphoramidite

InChI: InChI=1S/C58H78N6O12P2/c1-40(2)63(41(3)4)77(72-33-19-32-59)73-36-37-74-78(64(42(5)6)43(7)8)76-52-51(39-71-58(46-22-17-14-18-23-46,47-24-28-49(68-11)29-25-47)48-26-30-50(69-12)31-27-48)75-56(53(52)70-35-34-67-10)62-38-44(9)54(61-57(62)66)60-55(65)45-20-15-13-16-21-45/h13-18,20-31,38,40-43,51-53,56H,19,33-37,39H2,1-12H3,(H,60,61,65,66)/t51-,52-,53-,56-,77?,78?/m1/s1

ethane-1,2-di(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-bis(diisopropylphosphoramidite)

Description: ethane-1,2-di(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-bis(diisopropylphosphoramidite) is employed in the solid-phase synthesis of oligonucleotides with specific modifications, enhancing their stability and target affinity for applications in molecular biology and biotechnology.

CAT: BRP-00606

Molecular Formula: C96H116N8O20P2

Molecular Weight: 1763.97

Purity: ≥92%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: ZRLNUNRPDXULMT-SUWRQQMKSA-N

IUPAC Name: bis((2R,3R,4R,5R)-5-(4-benzamido-5-methyl-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl) ethane-1,2-diyl bis(diisopropylphosphoramidite)

InChI: InChI=1S/C96H116N8O20P2/c1-63(2)103(64(3)4)125(123-83-81(61-117-95(71-33-25-19-26-34-71,73-37-45-77(111-13)46-38-73)74-39-47-78(112-14)48-40-74)121-91(85(83)115-55-53-109-11)101-59-67(9)87(99-93(101)107)97-89(105)69-29-21-17-22-30-69)119-57-58-120-126(104(65(5)6)66(7)8)124-84-82(62-118-96(72-35-27-20-28-36-72,75-41-49-79(113-15)50-42-75)76-43-51-80(114-16)52-44-76)122-92(86(84)116-56-54-110-12)102-60-68(10)88(100-94(102)108)98-90(106)70-31-23-18-24-32-70/h17-52,59-60,63-66,81-86,91-92H,53-58,61-62H2,1-16H3,(H,97,99,105,107)(H,98,100,106,108)/t81-,82-,83-,84-,85-,86-,91-,92-,125?,126?/m1/s1

ethane-1,2-di(5'-O-DMTr-2'-O-MOE-rA(Bz)-3'-oxy)-bis(diisopropylphosphoramidite)

Description: ethane-1,2-di(5'-O-DMTr-2'-O-MOE-rA(Bz)-3'-oxy)-bis(diisopropylphosphoramidite) is utilized in the solid-phase synthesis of oligonucleotides with specific modifications, enhancing their stability and target affinity for applications in molecular biology and biotechnology.

CAT: BRP-00607

Molecular Formula: C96H112N12O18P2

Molecular Weight: 1783.97

Purity: ≥92%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: JUHDGWSQBXOHFV-IFGMRGENSA-N

IUPAC Name: bis((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl) ethane-1,2-diyl bis(diisopropylphosphoramidite)

InChI: InChI=1S/C96H112N12O18P2/c1-63(2)107(64(3)4)127(125-83-79(57-119-95(69-31-23-17-24-32-69,71-35-43-75(113-11)44-36-71)72-37-45-76(114-12)46-38-72)123-93(85(83)117-53-51-111-9)105-61-101-81-87(97-59-99-89(81)105)103-91(109)67-27-19-15-20-28-67)121-55-56-122-128(108(65(5)6)66(7)8)126-84-80(58-120-96(70-33-25-18-26-34-70,73-39-47-77(115-13)48-40-73)74-41-49-78(116-14)50-42-74)124-94(86(84)118-54-52-112-10)106-62-102-82-88(98-60-100-90(82)106)104-92(110)68-29-21-16-22-30-68/h15-50,59-66,79-80,83-86,93-94H,51-58H2,1-14H3,(H,97,99,103,109)(H,98,100,104,110)/t79-,80-,83-,84-,85-,86-,93-,94-,127?,128?/m1/s1

ethane-1,2-di(5'-O-DMTr-2'-O-MOE-rG(iBu)-3'-oxy)-bis(diisopropylphosphoramidite)

Description: ethane-1,2-di(5'-O-DMTr-2'-O-MOE-rG(iBu)-3'-oxy)-bis(diisopropylphosphoramidite) is employed in the solid-phase synthesis of oligonucleotides with specific modifications, enhancing their stability and target affinity for applications in molecular biology and biotechnology.

CAT: BRP-00608

Molecular Formula: C90H116N12O20P2

Molecular Weight: 1747.93

Purity: ≥92%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: DJTWFMQESYMPJM-FHQSMYATSA-N

IUPAC Name: bis((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl) ethane-1,2-diyl bis(diisopropylphosphoramidite)

InChI: InChI=1S/C90H116N12O20P2/c1-55(2)81(103)95-87-93-79-73(83(105)97-87)91-53-99(79)85-77(113-47-45-107-13)75(71(119-85)51-115-89(61-25-21-19-22-26-61,63-29-37-67(109-15)38-30-63)64-31-39-68(110-16)40-32-64)121-123(101(57(5)6)58(7)8)117-49-50-118-124(102(59(9)10)60(11)12)122-76-72(120-86(78(76)114-48-46-108-14)100-54-92-74-80(100)94-88(98-84(74)106)96-82(104)56(3)4)52-116-90(62-27-23-20-24-28-62,65-33-41-69(111-17)42-34-65)66-35-43-70(112-18)44-36-66/h19-44,53-60,71-72,75-78,85-86H,45-52H2,1-18H3,(H2,93,95,97,103,105)(H2,94,96,98,104,106)/t71-,72-,75-,76-,77-,78-,85-,86-,123?,124?/m1/s1

di(5'-O-DMTr-2'-O-MOE-rG(iBu)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite)

Description: di(5'-O-DMTr-2'-O-MOE-rG(iBu)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite) consists of two molecules of 5'-O-DMTr-2'-O-MOE-rG(iBu)-3'-oxy connected by an ethane-1,2-diyl linker, with each end functionalized with a diisopropylphosphoramidite group. The guanosine (rG) nucleoside units are modified with a 2'-O-methoxyethyl (MOE) group and isobutyryl (iBu) protection on the guanine amino group. This compound is utilized in oligonucleotide synthesis for the introduction of guanosine modifications, enhancing stability and target specificity in RNA sequences.

CAT: BRP-00609

Molecular Formula: C92H120N12O21P2

Molecular Weight: 1791.98

Purity: ≥92%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: MSPWBBNFOKRACO-QBSMUBNASA-N

InChI: InChI=1S/C92H120N12O21P2/c1-57(2)83(105)97-89-95-81-75(85(107)99-89)93-55-101(81)87-79(116-49-45-109-13)77(73(122-87)53-118-91(63-25-21-19-22-26-63,65-29-37-69(111-15)38-30-65)66-31-39-70(112-16)40-32-66)124-126(103(59(5)6)60(7)8)120-51-47-115-48-52-121-127(104(61(9)10)62(11)12)125-78-74(123-88(80(78)117-50-46-110-14)102-56-94-76-82(102)96-90(100-86(76)108)98-84(106)58(3)4)54-119-92(64-27-23-20-24-28-64,67-33-41-71(113-17)42-34-67)68-35-43-72(114-18)44-36-68/h19-44,55-62,73-74,77-80,87-88H,45-54H2,1-18H3,(H2,95,97,99,105,107)(H2,96,98,100,106,108)/t73-,74-,77-,78-,79-,80-,87-,88-,126?,127?/m1/s1

di(5'-O-DMTr-2'-O-MOE-rA(Bz)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite)

Description: di(5'-O-DMTr-2'-O-MOE-rA(Bz)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite) contains two molecules of 5'-O-DMTr-2'-O-MOE-rA(Bz)-3'-oxy linked by an ethane-1,2-diyl linker, with each end capped with a diisopropylphosphoramidite group. The adenosine (rA) nucleoside units are modified with a 2'-O-methoxyethyl (MOE) group and benzoyl (Bz) protection on the adenine amino group. It is employed in oligonucleotide synthesis to incorporate adenosine modifications, enhancing stability and target affinity in RNA sequences.

CAT: BRP-00610

Molecular Formula: C98H116N12O19P2

Molecular Weight: 1828.02

Purity: ≥92%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: HYMLNNFAMXTLQA-DEYJQIQZSA-N

InChI: InChI=1S/C98H116N12O19P2/c1-65(2)109(66(3)4)130(128-85-81(59-122-97(71-31-23-17-24-32-71,73-35-43-77(115-11)44-36-73)74-37-45-78(116-12)46-38-74)126-95(87(85)120-55-51-113-9)107-63-103-83-89(99-61-101-91(83)107)105-93(111)69-27-19-15-20-28-69)124-57-53-119-54-58-125-131(110(67(5)6)68(7)8)129-86-82(60-123-98(72-33-25-18-26-34-72,75-39-47-79(117-13)48-40-75)76-41-49-80(118-14)50-42-76)127-96(88(86)121-56-52-114-10)108-64-104-84-90(100-62-102-92(84)108)106-94(112)70-29-21-16-22-30-70/h15-50,61-68,81-82,85-88,95-96H,51-60H2,1-14H3,(H,99,101,105,111)(H,100,102,106,112)/t81-,82-,85-,86-,87-,88-,95-,96-,130?,131?/m1/s1

di(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite)

Description: di(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite) features two molecules of 5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy connected by an ethane-1,2-diyl linker, with each end bearing a diisopropylphosphoramidite group. The 5-methylcytidine (5-Me-rC) nucleoside units are modified with a 2'-O-methoxyethyl (MOE) group and benzoyl (Bz) protection on the cytosine amino group. It is utilized in oligonucleotide synthesis for introducing modified cytidine residues, enhancing stability and target specificity in RNA sequences.

CAT: BRP-00611

Molecular Formula: C98H120N8O21P2

Molecular Weight: 1808.02

Purity: ≥92%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: JOFMESXERKIMQK-AFYKGNOXSA-N

InChI: InChI=1S/C98H120N8O21P2/c1-65(2)105(66(3)4)128(126-85-83(63-120-97(73-33-25-19-26-34-73,75-37-45-79(113-13)46-38-75)76-39-47-80(114-14)48-40-76)124-93(87(85)118-57-53-111-11)103-61-69(9)89(101-95(103)109)99-91(107)71-29-21-17-22-30-71)122-59-55-117-56-60-123-129(106(67(5)6)68(7)8)127-86-84(64-121-98(74-35-27-20-28-36-74,77-41-49-81(115-15)50-42-77)78-43-51-82(116-16)52-44-78)125-94(88(86)119-58-54-112-12)104-62-70(10)90(102-96(104)110)100-92(108)72-31-23-18-24-32-72/h17-52,61-62,65-68,83-88,93-94H,53-60,63-64H2,1-16H3,(H,99,101,107,109)(H,100,102,108,110)/t83-,84-,85-,86-,87-,88-,93-,94-,128?,129?/m1/s1

Bis(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-diisopropylphosphoramidite

Description: Bis(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-diisopropylphosphoramidite consists of two molecules of 5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy linked by a diisopropylphosphoramidite group. Each 5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy unit is equipped with a diisopropylphosphoramidite group, facilitating its integration into oligonucleotide synthesis. It is used to introduce modified 5-methylcytidine (5-Me-rC) residues into RNA sequences, enhancing stability and target specificity.

CAT: BRP-00612

Molecular Formula: C88H98N7O18P

Molecular Weight: 1572.73

Purity: ≥92%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20 °C

InChIKey: SISSXAOEXVVHFI-QEZASILESA-N

IUPAC Name: bis((2R,3R,4R,5R)-5-(4-benzamido-5-methyl-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(2-methoxyethoxy)tetrahydrofuran-3-yl) diisopropylphosphoramidite

InChI: InChI=1S/C88H98N7O18P/c1-57(2)95(58(3)4)114(112-75-73(55-108-87(63-29-21-15-22-30-63,65-33-41-69(102-9)42-34-65)66-35-43-70(103-10)44-36-66)110-83(77(75)106-51-49-100-7)93-53-59(5)79(91-85(93)98)89-81(96)61-25-17-13-18-26-61)113-76-74(56-109-88(64-31-23-16-24-32-64,67-37-45-71(104-11)46-38-67)68-39-47-72(105-12)48-40-68)111-84(78(76)107-52-50-101-8)94-54-60(6)80(92-86(94)99)90-82(97)62-27-19-14-20-28-62/h13-48,53-54,57-58,73-78,83-84H,49-52,55-56H2,1-12H3,(H,89,91,96,98)(H,90,92,97,99)/t73-,74-,75-,76-,77-,78-,83-,84-/m1/s1

3'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-5'-CE-Phosphoramidite

3'-O-DMTr-2'-O-MOE-rA(Bz)-5'-CE-Phosphoramidite

3'-O-DMTr-2'-O-MOE-rG(iBu)-5'-CE-Phosphoramidite

U PMO Monomer

O6-(p-tolyl pivalate)-N2-PhAc protected G PMO Monomer

4-(((9-((2R,6S)-6-(((Chloro(dimethylamino)phosphoryl)oxy)methyl)-4-tritylmorpholin-2-yl)-2-(2-phenylacetamido)-9H-purin-6-yl)oxy)methyl)phenyl pivalate

DMTr-2'-O-4'-C-ethylene-rU-3'-CE-Phosphoramidite

DMTr-2'-O-4'-C-ethylene-rC(Bz)-3'-CE-Phosphoramidite

DMTr-2'-O-4'-C-ethylene-rA(Bz)-3'-CE-Phosphoramidite

DMTr-2'-O-4'-C-ethylene-rG(iBu)-3'-CE-Phosphoramidite

DMTr-2'-O-C22-rA(Bz)-3'-CE-Phosphoramidite

5'-O-DMT-2'-O-MOE-rG(iBu)-3'-((2-cyanoethoxy)(diisopropylamino)phosphoramidite)-ethyl-diisopropylphosphoramidite

5'-O-DMT-2'-O-MOE-5-Me-rC(Bz)-3'-((2-cyanoethoxy)(diisopropylamino)phosphoramidite)-ethyl-diisopropylphosphoramidite

ethane-1,2-di(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-bis(diisopropylphosphoramidite)

ethane-1,2-di(5'-O-DMTr-2'-O-MOE-rA(Bz)-3'-oxy)-bis(diisopropylphosphoramidite)

ethane-1,2-di(5'-O-DMTr-2'-O-MOE-rG(iBu)-3'-oxy)-bis(diisopropylphosphoramidite)

di(5'-O-DMTr-2'-O-MOE-rG(iBu)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite)

di(5'-O-DMTr-2'-O-MOE-rA(Bz)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite)

di(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-(oxybis(ethane-1,2-diyl))-bis(diisopropylphosphoramidite)

Bis(5'-O-DMTr-2'-O-MOE-5-Me-rC(Bz)-3'-oxy)-diisopropylphosphoramidite

Our Products

Liposome Products

MicroRNA Products

mRNA Products

siRNA Products

RNA Synthesis Reagents

Cap Analogs

CPGs for Oligo Synthesis

Nucleosides

Nucleotides

Phosphoramidites